Esperion Therapeutics (ESPR) Q1 Earnings and Revenues Surpass EstimatesZacks Investment Research • 05/08/19
Small-Cap Biotech Esperion Surges On FDA Acceptance Of Cholesterol Drug ApplicationsBenzinga • 05/06/19
Esperion Therapeutics (ESPR) Down 12.9% Since Last Earnings Report: Can It Rebound?Zacks Investment Research • 03/30/19